Clinical Cardiology Alert – October 1, 2020
October 1, 2020
View Issues
-
Management of Cardiac Arrest Patients Without STEMI
Since there were no significant differences in outcomes at 90 days or one year, coronary interventions in successfully resuscitated cardiac arrest patients without evidence of STEMI or cardiogenic shock can be delayed until neurologic recovery is evident.
-
Perioperative Atrial Fibrillation: Is It Important?
A large epidemiologic study with validated endpoints of patients with atrial fibrillation after non-cardiac surgery demonstrated such patients experience a higher incidence of subsequent atrial fibrillation, stroke, transient ischemic attacks, and all-cause mortality over five years of follow up.
-
When Aortic Stenosis Is Almost Severe: What Happens Next?
A study of patients with normal flow, low gradients, normal left ventricular systolic function but with calculated aortic valve areas <1.0 cm2 showed that about half of them progressed to severe aortic stenosis during the 25-month median follow-up period.
-
Pulmonary Artery Denervation: A Promising Treatment Option for CTEPH
A trial of patients with residual chronic thromboembolic pulmonary hypertension following pulmonary endarterectomy showed pulmonary artery denervation is superior to medical management with riociguat.
-
Does BAMI Spell the End for Cell-Based Therapy After Acute Myocardial Infarction?
Investigators tested the mortality benefit of intracoronary bone marrow cells in patients with successfully reperfused acute myocardial infarction. They observed no effect on mortality.